David Hung insider trades: NovoCure (NVCR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
and 4 more companies
Open-market buys and sales
41 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NVCR | ↓ Sell | 2,945 | $15.77 | $46K | Direct | Jun 3, 2026 (1d) |
| Jun 16, 2025 | NUVB | ↑ Buy | 500,000 | $1.79 | $894K | Direct | Jun 18, 2025 (2d) |
| Jun 3, 2025 | NVCR | ↓ Sell | 999 | $17.30 | $17K | Direct | Jun 4, 2025 (1d) |
| Apr 7, 2025 | NUVB | ↑ Buy | 500,000 | $1.64 | $820K | Direct | Apr 8, 2025 (1d) |
| Apr 17, 2017 | AXON | ↑ Buy | 539,375 | $18.54 | $10.0M | Direct | Apr 19, 2017 (2d) |
| Mar 4, 2016 | MDVN | ↓ Sell | 5,085 | $41.10 | $209K | Direct | Mar 7, 2016 (3d) |
| Feb 4, 2016 | MDVN | ↓ Sell | 6,350 | $31.18 | $198K | Direct | Feb 5, 2016 (1d) |
| Dec 3, 2015 | MDVN | ↓ Sell | 10,950 | $43.10 | $472K | Direct | Dec 4, 2015 (1d) |
| Mar 2, 2015 | MDVN | ↓ Sell | 100,891 | $120.83 | $12.2M | Direct | Mar 2, 2015 (0d) |
| Feb 26, 2015 | MDVN | ↓ Sell | 19,109 | $120.12 | $2.3M | Direct | Feb 27, 2015 (1d) |
| Feb 4, 2015 | MDVN | ↓ Sell | 3,190 | $100.48 | $321K | Direct | Feb 6, 2015 (2d) |
| Jan 20, 2015 | MDVN | ↓ Sell10b5-1 | 100,000 | $108.14 | $10.8M | Direct | Jan 22, 2015 (2d) |
| Dec 3, 2014 | MDVN | ↓ Sell | 5,420 | $113.00 | $612K | Direct | Dec 4, 2014 (1d) |
| Jan 27, 2014 | MDVN | ↓ Sell10b5-1 | 150,000 | $73.50 | $11.0M | Direct | Jan 28, 2014 (1d) |
| Dec 3, 2013 | MDVN | ↓ Sell | 15,050 | $62.61 | $942K | Direct | Dec 4, 2013 (1d) |
| Jul 5, 2013 | MDVN | ↓ Sell10b5-1 | 30,885 | $55.45 | $1.7M | Direct | Jul 9, 2013 (4d) |
| Apr 23, 2013 | MDVN | ↓ Sell10b5-1 | 1,615 | $55.00 | $89K | Direct | Apr 25, 2013 (2d) |
| Apr 22, 2013 | MDVN | ↓ Sell10b5-1 | 67,500 | $55.12 | $3.7M | Direct | Apr 22, 2013 (0d) |
| Apr 11, 2013 | MDVN | ↓ Sell10b5-1 | 50,000 | $52.62 | $2.6M | Direct | Apr 15, 2013 (4d) |
| Apr 5, 2013 | MDVN | ↓ Sell10b5-1 | 50,000 | $50.17 | $2.5M | Direct | Apr 9, 2013 (4d) |
| Dec 10, 2012 | MDVN | ↓ Sell | 10,246 | $54.42 | $558K | Direct | Dec 11, 2012 (1d) |
| Oct 4, 2012 | MDVN | ↓ Sell10b5-1 | 50,000 | $57.92 | $2.9M | Direct | Oct 5, 2012 (1d) |
| Sep 4, 2012 | MDVN | ↓ Sell10b5-1 | 25,000 | $111.16 | $2.8M | Direct | Sep 5, 2012 (1d) |
| Jul 3, 2012 | MDVN | ↓ Sell10b5-1 | 25,000 | $95.05 | $2.4M | Direct | Jul 9, 2012 (6d) |
| May 14, 2012 | MDVN | ↓ Sell10b5-1 | 25,000 | $85.86 | $2.1M | Direct | May 16, 2012 (2d) |
| Feb 8, 2012 | MDVN | ↓ Sell10b5-1 | 100,000 | $70.19 | $7.0M | Direct | Feb 9, 2012 (1d) |
| Dec 7, 2009 | MDVN | ↓ Sell | 25,000 | $33.27 | $832K | Direct | Dec 8, 2009 (1d) |
| Sep 10, 2009 | MDVN | ↓ Sell | 25,000 | $25.84 | $646K | Direct | Sep 11, 2009 (1d) |
| Sep 10, 2009 | OPXA | ↓ Sell | 20,200 | $4.18 | $84K | Direct | Sep 10, 2009 (0d) |
| Aug 26, 2009 | OPXA | ↓ Sell | 26,800 | $1.46 | $39K | Direct | Aug 27, 2009 (1d) |
| Aug 20, 2009 | OPXA | ↓ Sell | 5 | $1.60 | $8 | Direct | Aug 21, 2009 (1d) |
| Jul 1, 2009 | MDVN | ↓ Sell | 25,000 | $22.62 | $565K | Direct | Jul 2, 2009 (1d) |
| Mar 18, 2009 | MDVN | ↓ Sell | 25,000 | $16.69 | $417K | Direct | Mar 19, 2009 (1d) |
| Dec 3, 2008 | MDVN | ↓ Sell | 25,000 | $13.90 | $347K | Direct | Dec 5, 2008 (2d) |
| Sep 25, 2008 | MDVN | ↓ Sell | 25,000 | $29.69 | $742K | Direct | Sep 29, 2008 (4d) |
| Jun 9, 2008 | MDVN | ↓ Sell | 25,000 | $14.89 | $372K | Direct | Jun 11, 2008 (2d) |
| Mar 3, 2008 | MDVN | ↓ Sell | 25,000 | $15.64 | $391K | Direct | Mar 5, 2008 (2d) |
| Dec 3, 2007 | MDVN | ↓ Sell | 25,000 | $13.14 | $328K | Direct | Dec 5, 2007 (2d) |
| Sep 19, 2007 | MDVN | ↓ Sell | 25,000 | $19.01 | $475K | Direct | Sep 21, 2007 (2d) |
| Jun 5, 2007 | MDVN | ↓ Sell | 25,000 | $16.42 | $411K | Direct | Jun 7, 2007 (2d) |
| Mar 16, 2007 | MDVN | ↓ Sell | 25,000 | $17.80 | $445K | Direct | Mar 20, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCR insiders
Open-market trades in the last 12 months
About David Hung's insider trades
David Hung is an insider at NovoCure (NVCR). Since Mar 16, 2007, David has reported 3 open-market purchases worth $11.7M and 38 sales worth $73.7M on SEC Form 4. In the last 12 months: 1 sale ($46K).
12 sales (67% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (39 filings), option exercises (5 filings), other transactions (3 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.